Skip to main content
Clinical Trials/NCT01955369
NCT01955369
Completed
Not Applicable

Amyotrophic Lateral Sclerosis Registry Rhineland-Palatinate

Klinikum Ludwigshafen1 site in 1 country200 target enrollmentOctober 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Amyotrophic Lateral Sclerosis
Sponsor
Klinikum Ludwigshafen
Enrollment
200
Locations
1
Primary Endpoint
Death
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

There is a lack of prospective and population-based epidemiological data on amyotrophic lateral sclerosis in Germany so far. The purpose of this registry is to investigate the incidence, course and phenotypic variety of ALS in Rhineland-Palatinate, a South-West German state of about 4 million inhabitants.

Registry
clinicaltrials.gov
Start Date
October 2009
End Date
September 2015
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinikum Ludwigshafen
Responsible Party
Principal Investigator
Principal Investigator

Joachim Wolf

Senior neurologist of the Dept. of Neurology

Klinikum Ludwigshafen

Eligibility Criteria

Inclusion Criteria

  • diagnosis of amyotrophic lateral sclerosis according to revised El Escorial criteria
  • minimum of 18 years
  • minimum of 6 months of residency in Rhinelnad-Palatinate

Exclusion Criteria

  • patients below 18 years
  • ALS patients outside Rhineland-Palatinate

Outcomes

Primary Outcomes

Death

Time Frame: an average of 3 years

death of participating ALS patients independent of the cause of death

Secondary Outcomes

  • Tracheostomy(an average of 3 years)

Study Sites (1)

Loading locations...

Similar Trials